Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
复制标题
大麻素受体2的激活可促进2型天然淋巴细胞扩增并加剧气道高反应性。
DOI:
10.1016/j.jaci.2021.09.037
复制
发表时间:
2022-05
影响因子:
14.2
通讯作者:
Akbari, Omid
中科院分区:
文献类型:
--
作者:
Hurrell, Benjamin P.;Helou, Doumet Georges;Shafiei-Jahani, Pedram;Howard, Emily;Painter, Jacob D.;Quach, Christine;Akbari, Omid
Cannabinoids modulate the activation of immune cells and physiological processes in the lungs. Group-2 innate lymphoid cells (ILC2)s are central players in type-2 asthma, but how cannabinoids modulate ILC2 activation remains to be elucidated Our goal is to investigate the effects of cannabinoids on ILC2s and their role in asthma. A combination of Cannabinoid receptor (CB)2 KO mice, CB2 antagonist and agonist were used in the mouse models of IL-33, IL-25 and Alternaria alternata ILC2-dependent airway inflammation, and RNA sequencing was performed to assess transcriptomic changes in ILC2s. Humanized mice were used to assess the role of CB2 signaling in human ILC2s. We here provide evidence that CB2 signaling in ILC2s is important for the development of ILC2-driven airway inflammation in both mice and human. We showed that both naïve and activated murine pulmonary ILC2s express CB2. CB2 signaling did not affect ILC2 homeostasis at steady state, but strikingly stimulated ILC2 proliferation and function upon activation. As a result, ILC2s lacking CB2 induced lower lung inflammation, as we made similar observations using a CB2 antagonist. Conversely, CB2 agonism remarkably exacerbated ILC2-driven airway hyperreactivity and lung inflammation. Mechanistically, transcriptomic and protein analysis revealed that CB2 signaling induced CREB phosphorylation in ILC2s. Human ILC2s expressed CB2, as CB2 antagonism and agonism showed opposing effects on ILC2 effector function and development of airway hyperreactivity in humanized mice. Collectively, our results define CB2 signaling in ILC2s as an important modulator of airway inflammation. Our findings highlight the stimulatory capacity of cannabinoids on ILC2s and offer new therapeutic avenues, including the use of substances or pathways able to modulate CB2 capable of alleviating lung function in patients with lung inflammation. This study is the first to highlight the role of CB2 signaling in promoting ILC2-dependent airway inflammation, opening avenues for the development of novel adapted therapeutic strategies.
登录
查看更多内容
影响因子:
3.7
作者:
Basu S;Ray A;Dittel BN
通讯作者:
Dittel BN
影响因子:
12.4
作者:
Ferrini ME;Hong S;Stierle A;Stierle D;Stella N;Roberts K;Jaffar Z
通讯作者:
Jaffar Z
影响因子:
4.8
作者:
D'Argenio, G;Valenti, M;Di Marzo, V
通讯作者:
Di Marzo, V
DOI:
10.1111/j.1432-1033.1995.tb20780.x
发表时间:
1995-08-15
期刊:
EUROPEAN JOURNAL OF BIOCHEMISTRY
影响因子:
--
作者:
GALIEGUE, S;MARY, S;CASELLAS, P
通讯作者:
CASELLAS, P
影响因子:
2.8
作者:
Braun, Andrea;Engel, Tabea;Mempel, Martin
通讯作者:
Mempel, Martin